Evita Platform Aids Hereditary Cancer Detection in Portugal
The Evita Platform, a tool for assessing hereditary cancer risk, has gained traction in Portugal. Over 2,300 individuals have used the platform, with the majority advised to seek genetic counseling. This comes as Portugal faces around 7,000 hereditary cancer cases annually.
The Evita Platform offers a simple 10-question questionnaire based on national recommendations. If a user answers yes to any question, they are advised to seek genetic counseling. This is crucial as family doctors may struggle to recognize hereditary cancer patterns in family history.
The platform has seen significant use, with 3,215 users and 2,310 test takers. Of these, 81% received an elevated risk indication. Evita plans to offer genetic counseling and psychological support via telemedicine in the future.
The Evita Platform is aiding in the early detection of hereditary cancer in Portugal. With over 2,300 users and a high percentage advised to seek genetic counseling, it is helping to address the country's annual 7,000 hereditary cancer cases. The platform's future plans to offer telemedicine services further enhance its potential impact.
Read also:
- Americans Lose Insurance Under New Tax Legislation, Affecting 10 Million Citizens
- Pro-Life Group Condemns FDA's Approval of Generic Abortion Drug
- Trump Signs Law Defunding Planned Parenthood, Threatening Healthcare Access for Millions
- Historian Ute Frevert Explores Germans' Emotional Bond With Constitutions
